Skip to main content

Find Clinical Trials

Home
Conditions
Epilepsies, Myoclonic

Clinical trial condition

Epilepsies, Myoclonic

Explore clinical trials studying Epilepsies, Myoclonic. Study availability and eligibility vary by location and protocol.

16 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Epilepsies, Myoclonic trial results

Completed

Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion Bodies

NCT00006176

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

NCT00357669

Conditions: Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations: Kuopio, Finland

Tampere, Finland

Marseille, France

Montpellier, France

View all 13 locations

View Trial Details

Completed

Ketogenic Diet in Lafora Disease

NCT00007124

Conditions: Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +23 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation

NCT07084311

Conditions: Brain Diseases, Central Nervous System Diseases, Dentatorubral-Pallidoluysian Atrophy, +6 more
Locations: Hawaii Pacific Neuroscience Honolulu, Hawaii, United States

View Trial Details

Active, Not Recruiting

Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation

NCT06706388

Conditions: Brain Diseases, Central Nervous System Diseases, Dentatorubral-Pallidoluysian Atrophy, +6 more
Locations: Columbia University New York, United States

View Trial Details

Active, Not Recruiting

Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation

NCT07221760

Conditions: Brain Diseases, Central Nervous System Diseases, Dentatorubral-Pallidoluysian Atrophy, +6 more
Locations: Dell Children's Austin, Texas, United States

View Trial Details